{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:48:06Z","timestamp":1788994086189,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Calcitonin gene-related peptide (CGRP) dilates cranial arteries and triggers headache. The CGRP signaling pathway is partly dependent on activation of ATP-sensitive potassium (K<jats:sub><jats:italic>ATP<\/jats:italic><\/jats:sub>) channels. Here, we investigated the effect of the K<jats:sub><jats:italic>ATP<\/jats:italic><\/jats:sub> channel blocker glibenclamide on CGRP-induced headache and vascular changes in healthy volunteers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a randomized, double-blind, placebo-controlled, cross-over study, 20 healthy volunteers aged 18\u201327 years were randomly allocated to receive an intravenous infusion of 1.5 \u03bcg\/min CGRP after oral pretreatment with glibenclamide (glibenclamide-CGRP day) or placebo (placebo-CGRP day). The primary endpoints were the difference in incidence of headache and the difference in area under the curve (AUC) for headache intensity scores (0\u201314 h) between glibenclamide and placebo. The secondary endpoints were the difference in AUC for middle cerebral artery blood flow velocity (V<jats:sub><jats:italic>MCA<\/jats:italic><\/jats:sub>), superficial temporal artery (STA) and radial artery (RA) diameter, facial flushing, heart rate (HR) and mean arterial blood pressure (MAP) (0\u20134 h) between glibenclamide and placebo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found no significant difference in the incidence of headache between glibenclamide-CGRP day (14\/20, 70%) and placebo-CGRP day (19\/20, 95%) (<jats:italic>P<\/jats:italic> = 0.06). The AUC for headache intensity, V<jats:sub><jats:italic>MCA<\/jats:italic><\/jats:sub>, STA, RA, facial skin blood flow, HR, and MAP did not differ between glibenclamide-CGRP day compared to placebo-CGRP day (<jats:italic>P &amp;gt;<\/jats:italic> 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pretreatment with a non-selective K<jats:sub><jats:italic>ATP<\/jats:italic><\/jats:sub> channel inhibitor glibenclamide did not attenuate CGRP-induced headache and hemodynamic changes in healthy volunteers. We suggest that CGRP-induced responses could be mediated via activation of specific isoforms of sulfonylurea receptor subunits of K<jats:sub><jats:italic>ATP<\/jats:italic><\/jats:sub> channel.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphys.2021.652136","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T09:36:15Z","timestamp":1623404175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["The Effect of KATP Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers"],"prefix":"10.3389","volume":"12","author":[{"given":"Hande","family":"Coskun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Azzahra","family":"Elbahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Al-Mahdi","family":"Al-Karagholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashmat","family":"Ghanizada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Sheykhzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab136","article-title":"Opening of ATP sensitive potassium channels causes migraine attacks with aura.","author":"Al-Karagholi","year":"","journal-title":"Brain"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/2515816319884937","article-title":"The vascular effect of glibenclamide?: A systematic review.","volume":"2","author":"Al-karagholi","year":"","journal-title":"Cephalalgia Rep."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1177\/0333102419888490","article-title":"Extracranial activation of ATP-sensitive potassium channels induces vasodilation without nociceptive effects.","volume":"39","author":"Al-Karagholi","year":"","journal-title":"Cephalalgia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/head.13634","article-title":"Levcromakalim, an adenosine triphosphate-sensitive potassium channel opener, dilates extracerebral but not cerebral arteries.","volume":"59","author":"Al-Karagholi","year":"","journal-title":"Headache"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1177\/0333102420940681","article-title":"Opening of BKCa channels alters cerebral hemodynamic and causes headache in healthy volunteers.","volume":"40","author":"Al-Karagholi","year":"","journal-title":"Cephalalgia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002238","article-title":"Opening of BKCa channels causes migraine attacks.","author":"Al-Karagholi","year":"","journal-title":"PAIN"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0333102420949863","article-title":"Effect of KATP channel blocker glibenclamide on levcromakalim-induced headache.","volume":"40","author":"Al-Karagholi","year":"","journal-title":"Cephalalgia"},{"key":"B8","first-page":"271678X20959294","article-title":"Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteers.","volume":"7","author":"Al-Karagholi","year":"","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/brain\/awz199","article-title":"Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine.","volume":"142","author":"Al-Karagholi","year":"","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s10194-017-0800-8","article-title":"The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine.","volume":"18","author":"Al-Karagholi","year":"2017","journal-title":"J. Headache Pain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s001250050167","article-title":"Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects.","volume":"37","author":"Ampudia-Blasco","year":"1994","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0333102416684344","article-title":"CGRP in human models of primary headaches.","volume":"38","author":"Ashina","year":"2018","journal-title":"Cephalalgia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/164_2018_128","article-title":"CGRP in human models of migraine.","volume":"255","author":"Ashina","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMra1915327","article-title":"Migraine.","volume":"383","author":"Ashina","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/s0140-6736(20)32162-0","article-title":"Migraine: disease characterisation, biomarkers, and precision medicine.","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1074\/jbc.275.2.717","article-title":"Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers.","volume":"275","author":"Babenko","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1152\/ajpregu.2000.278.6.R1667","article-title":"Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans.","volume":"278","author":"Bayerle-Eder","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator.","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0333102420925513","article-title":"ATP sensitive potassium (KATP) channel inhibition: a promising new drug target for migraine.","volume":"40","author":"Christensen","year":"2020","journal-title":"Cephalalgia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"Krause DiN. CGRP as the target of new migraine therapies - Successful translation from bench to clinic.","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","article-title":"Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.","volume":"14","author":"Eftekhari","year":"2013","journal-title":"J. Pain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/head.13747","article-title":"Sumatriptan does not antagonize CGRP-induced symptoms in healthy volunteers.","volume":"60","author":"Falkenberg","year":"2020","journal-title":"Headache"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/00004647-199810000-00001","article-title":"Role of potassium channels in regulation of cerebral vascular tone.","volume":"18","author":"Faraci","year":"1998","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1540\/jsmr.30.9","article-title":"Relaxant isolated effects small of calcitonin renal arteries in stroke-prone rats peptide on spontaneously hypertensive of rats.","volume":"30","author":"Gao","year":"1994","journal-title":"J. Smooth Muscle Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0333102419864507","article-title":"PACAP27 induces migraine-like attacks in migraine patients.","volume":"40","author":"Ghanizada","year":"","journal-title":"Cephalalgia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0333102420970489","article-title":"Nocebo response in human models of migraine: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers.","volume":"41","author":"Ghanizada","year":"","journal-title":"Cephalalgia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/01.cir.0000155252.23933.2d","article-title":"Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study.","volume":"111","author":"Gori","year":"2005","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.1526-4610.2008.01205.x","article-title":"Role of KATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.","volume":"48","author":"Gozalov","year":"2008","journal-title":"Headache"},{"key":"B29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1468-2982.2004.00848.x","article-title":"Role of KATP channels in the regulation of rat dura and pia artery diameter.","volume":"25","author":"Gozalov","year":"2005","journal-title":"Cephalalgia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","article-title":"Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.","volume":"30","author":"Hansen","year":"2010","journal-title":"Cephalalgia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00021.2009","article-title":"Inwardly rectifying potassium channels: their structure, function, and physiological roles.","volume":"90","author":"Hibino","year":"2010","journal-title":"Physiol. Rev."},{"key":"B32","first-page":"39","article-title":"Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles.","volume":"270","author":"Hong","year":"1996","journal-title":"Am. J. Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1177\/0271678x19874295","article-title":"Cerebrovascular effects of endothelin-1 investigated using high-resolution magnetic resonance imaging in healthy volunteers.","volume":"40","author":"Hougaard","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/0333102420981666","article-title":"Hypersensitivity to calcitonin gene-related peptide in chronic migraine.","volume":"41","author":"Iljazi","year":"2020","journal-title":"Cephalalgia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/s0896-6273(00)80124-5","article-title":"A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.","volume":"16","author":"Inagaki","year":"1996","journal-title":"Neuron"},{"key":"B36","first-page":"490","article-title":"Calcitonin gene-related peptide relaxes porcine coronary arteries via cyclic AMP-dependent mechanisms, but not activation of ATP-sensitive potassium channels.","volume":"265","author":"Kageyama","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/jcbfm.2015.84","article-title":"Expanding applications, accuracy, and interpretation of laser speckle contrast imaging of cerebral blood flow.","volume":"35","author":"Kazmi","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B38","first-page":"581","article-title":"Role of ATP-sensitive K+ channels in CGRP-induced dilatation of basilar artery in vivo.","volume":"265","author":"Kitazono","year":"1993","journal-title":"Am. J. Physiol."},{"key":"B39","first-page":"38","article-title":"ATP-sensitive K+ currents in cerebral arterial smooth muscle: pharmacological and hormonal modulation.","volume":"269","author":"Kleppisch","year":"1995","journal-title":"Am. J. Physiol."},{"key":"B40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11916-020-00911-6","article-title":"Latest insights into the pathophysiology of migraine: the ATP-sensitive potassium channels.","volume":"24","author":"Kokoti","year":"2020","journal-title":"Curr. Pain Headache Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine.","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s005920050081","article-title":"Glibenclamide: an old drug with a novel mechanism of action?","volume":"34","author":"Luzi","year":"1997","journal-title":"Acta Diabetol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/344770a0","article-title":"Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels.","volume":"344","author":"Nelson","year":"1990","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1468-2982.2004.00830.x","article-title":"The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers.","volume":"25","author":"Petersen","year":"","journal-title":"Cephalalgia"},{"key":"B45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.clpt.2004.10.001","article-title":"BIBN4096BS antagonizes human \u03b1-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.","volume":"77","author":"Petersen","year":"","journal-title":"Clin Pharmacol Ther."},{"key":"B46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0333102411430266","article-title":"K ATP channel openers in the trigeminovascular system.","volume":"32","author":"Ploug","year":"2012","journal-title":"Cephalalgia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/bjp.2008.86","article-title":"K ATP channel expression and pharmacological in vivo and in vitro studies of the K ATP channel blocker PNU-37883A in rat middle meningeal arteries.","volume":"154","author":"Ploug","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2008.10.041","article-title":"KATP channels in pig and human intracranial arteries.","volume":"601","author":"Ploug","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1113\/jphysiol.1994.sp020045","article-title":"Calcitonin gene-related peptide activated ATP-sensitive K+ currents in rabbit arterial smooth muscle via protein kinase A.","volume":"475","author":"Quayle","year":"1994","journal-title":"J. Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/sj.bjp.0703936","article-title":"Mechanism of CGRP-induced relaxation in rat intramural coronary arteries.","volume":"132","author":"Sheykhzade","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00125-006-0307-3","article-title":"Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular KATP channels.","volume":"49","author":"Stephan","year":"2006","journal-title":"Diabetologia"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition.","volume":"38","author":"Vincent","year":"2018","journal-title":"Cephalalgia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/0333102418798611","article-title":"Effect of the H 1 -antihistamine clemastine on PACAP38 induced migraine.","volume":"39","author":"Vollesen","year":"2019","journal-title":"Cephalalgia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00004872-199816050-00019","article-title":"Effects of glibenclamide on blood pressure and cardiovascular responsiveness in non-insulin dependent diabetes mellitus.","volume":"16","author":"Williams","year":"1998","journal-title":"J. Hypertens."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.652136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T09:36:25Z","timestamp":1623404185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.652136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":54,"alternative-id":["10.3389\/fphys.2021.652136"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.652136","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"article-number":"652136"}}